We are live on ! Find out more
DCLA

Douglas C. Lane & Associates Portfolio holdings

AUM $3.69B
1-Year Est. Return 0.11%
This Fund
S&P 500
This Quarter Est. Return
-0.45%
1 Year Est. Return
+0.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.35B
AUM Growth
+$41.9M
Cap. Flow
+$91.4M
Cap. Flow %
2.73%
Top 10 Hldgs %
20.42%
Holding
248
New
25
Increased
103
Reduced
91
Closed
15

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$14.9M
2
DINO icon
HF Sinclair
DINO
+$8.26M
3
SSYS icon
Stratasys
SSYS
+$7.67M
4
VLO icon
Valero Energy
VLO
+$7.25M
5
MPC icon
Marathon Petroleum
MPC
+$6.33M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$17.8M
2
KO icon
Coca-Cola
KO
+$6.05M
3
MMM icon
3M
MMM
+$5.98M
4
HRI icon
Herc Holdings
HRI
+$5.57M
5
WBD icon
Warner Bros
WBD
+$5.26M

Sector Composition

Rank Sector Weight
1 Industrials 19.4%
2 Technology 15.85%
3 Healthcare 15.09%
4 Consumer Discretionary 10.88%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
51
Abbott
ABT
$187B
$25.7M 0.77%
616,772
-117,197
-16% -$4.96M
XPO icon
52
XPO
XPO
$23B
$25.6M 0.76%
1,962,938
+249,874
+15% +$2.73M
IHS
53
DELISTED
IHS INC CL-A COM STK
IHS
$24.9M 0.74%
199,185
+5,350
+3% +$726K
LUX
54
DELISTED
Luxottica Group
LUX
$24.9M 0.74%
478,503
-1,100
-0.2% -$59.1K
JPM icon
55
JPMorgan Chase
JPM
$947B
$24.1M 0.72%
399,520
-13,838
-3% -$809K
BMY icon
56
Bristol-Myers Squibb
BMY
$131B
$24M 0.72%
469,470
+1,136
+0.2% +$56.7K
EXPD icon
57
Expeditors International
EXPD
$23.2B
$23.7M 0.71%
583,320
-32,215
-5% -$1.37M
TRI icon
58
Thomson Reuters
TRI
$43.4B
$23.7M 0.71%
559,908
+47,760
+9% +$2.07M
SNY icon
59
Sanofi
SNY
$103B
$23.2M 0.69%
410,618
+12,725
+3% +$683K
UN
60
DELISTED
Unilever NV New York Registry Shares
UN
$22.9M 0.68%
577,387
-20,223
-3% -$842K
ETN icon
61
Eaton
ETN
$174B
$21.9M 0.65%
345,404
+56,215
+19% +$3.99M
YHOO
62
DELISTED
Yahoo Inc
YHOO
$21M 0.63%
516,395
+68,157
+15% +$2.56M
CMCSK
63
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$21M 0.63%
392,687
-7,095
-2% -$380K
VLO icon
64
Valero Energy
VLO
$87.2B
$20.9M 0.62%
450,632
+143,800
+47% +$7.25M
VZ icon
65
Verizon
VZ
$195B
$20.8M 0.62%
415,198
-13,310
-3% -$662K
SLB icon
66
SLB Ltd
SLB
$76.5B
$20.7M 0.62%
203,852
-313
-0.2% -$34.1K
DIS icon
67
Walt Disney
DIS
$181B
$20.6M 0.62%
231,666
-39,127
-14% -$3.45M
BX icon
68
Blackstone
BX
$107B
$19.6M 0.58%
633,046
+13,920
+2% +$453K
ACN icon
69
Accenture
ACN
$105B
$19.5M 0.58%
239,737
-621
-0.3% -$49.8K
AAPL icon
70
Apple
AAPL
$4.56T
$19.4M 0.58%
771,000
-7,076
-0.9% -$174K
AXP icon
71
American Express
AXP
$231B
$19.3M 0.58%
220,678
+8,520
+4% +$767K
MPC icon
72
Marathon Petroleum
MPC
$84B
$18.6M 0.56%
440,082
+149,276
+51% +$6.33M
HAIN icon
73
Hain Celestial
HAIN
$53.5M
$18.1M 0.54%
352,864
+69,166
+24% +$3.22M
ITW icon
74
Illinois Tool Works
ITW
$84.8B
$17.8M 0.53%
210,691
-423
-0.2% -$36.6K
KRFT
75
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$17.8M 0.53%
315,306
+12,640
+4% +$731K
1 2
3
4 5

Similar funds

AM
Appaloosa Management Miami Beach, Florida $5.01B AUM 0.22% 1-Year Est. Return
NRECA
National Rural Electric Cooperative Association Arlington, Virginia $5.58B AUM 0.17% 1-Year Est. Return
ALA
Atherton Lane Advisers Menlo Park, California $1.72B AUM 0.32% 1-Year Est. Return
KIG
Kovitz Investment Group Chicago, Illinois $1.62B AUM 5.44% 1-Year Est. Return
GC
GW Capital Bellevue, Washington $1.44B AUM 5.7% 1-Year Est. Return
CC
Curian Capital Denver, Colorado $1.35B AUM 0.33% 1-Year Est. Return
CC
Chubb Corp Warren, New Jersey $1.24B AUM 0.59% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

Douglas C. Lane & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Douglas C. Lane & Associates held 248 positions worth $3.35B, up 1.3% from $3.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Douglas C. Lane & Associates's Q3 2014 filing shows 25 new, 103 increased, 91 reduced and 15 closed positions. Its largest new stake was Stratasys: 67,832 shares worth $8.19M. The largest sale was AbbVie, an estimated $17.8M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Douglas C. Lane & Associates's largest Q3 2014 buy was Stratasys: 67,832 shares worth $8.19M.
  • Douglas C. Lane & Associates added most to MetLife in Q3 2014, an estimated $14.9M increase.
  • Douglas C. Lane & Associates's biggest Q3 2014 reduction was AbbVie, cutting an estimated $17.8M.
  • Douglas C. Lane & Associates fully exited Carbo Ceramics Inc. in Q3 2014, selling an estimated $2.28M.
  • Douglas C. Lane & Associates's ten largest holdings make up 20% of its $3.35B portfolio in Q3 2014.
  • Douglas C. Lane & Associates opened 25 new positions and closed 15 in Q3 2014.
  • Douglas C. Lane & Associates's portfolio value rose 1.3% quarter-over-quarter to $3.35B.

Based on Douglas C. Lane & Associates's 13F filing for Q3 2014, filed 27 Oct 2014.